How Eli Lilly and Novo Nordisk have separated themselves from their rivals

• click to rate

  Posted by Two Blokes Apr 26 - Filed in Stock - 3 views
  
  Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior pharma & biotech analyst Tim Anderson describes how tariffs will impact the pharmaceutical stocks he covers.